Butabarbital Sodium
The sodium salt of butabarbital, a barbiturate sedative-hypnotic once used to treat insomnia and anxiety. Like other barbiturates, it has a significant risk of dependence, overdose, and drug interactions. It is rarely used today in the context of safer modern sleep aids.
Berat Molekul
234,2300 g/mol
TPSA
81,60 Ų
Mekanisme Kerja
Selectively blocks angiotensin II type 1 (AT1) receptors, preventing the vasoconstrictive and aldosterone-secreting effects of angiotensin II. This results in vasodilation, reduced sodium retention, and decreased blood pressure.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Selectively blocks angiotensin II type 1 (AT1) receptors, preventing the vasoconstrictive and aldosterone-secreting effects of angiotensin II. This results in vasodilation, reduced sodium retention, and decreased blood pressure.
Struktur 2D
Cite this structure
Embed this structure
SMILES
CCC(C)C1(CC)C(=O)[N-]C(=O)NC1=O.[Na+]
InChI
InChI=1S/C10H16N2O3.Na/c1-4-6(3)10(5-2)7(13)11-9(15)12-8(10)14;/h6H,4-5H2,1-3H3,(H2,11,12,13,14,15);/q;+1/p-1
Molecular Formula
C10H15N2NaO3
HBD / HBA
1 / 3
Ikatan yang Dapat Dirotasi
3
Atom Berat
16
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
Pertanyaan yang Sering Diajukan
The sodium salt of butabarbital, a barbiturate sedative-hypnotic once used to treat insomnia and anxiety. Like other barbiturates, it has a significant risk of dependence, overdose, and drug interactions. It is rarely used today in the context of safer modern sleep aids.
Selectively blocks angiotensin II type 1 (AT1) receptors, preventing the vasoconstrictive and aldosterone-secreting effects of angiotensin II. This results in vasodilation, reduced sodium retention, and decreased blood pressure.
Yes, Butabarbital Sodium is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200982. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 23690439. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="butabarbital-sodium"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/butabarbital-sodium/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/butabarbital-sodium/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/butabarbital-sodium/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="butabarbital-sodium"></drugfyi-drug>